San Francisco, CA — Synthetic biology company Pareto Biotechnologies today announces a technology partnership with global bioengineering leader DNA2.0, enabling Pareto to further develop its technology for quick-to-market products. The integration of Pareto’s rational-based design approach and DNA2.0’s machine learning optimization technologies, such as ProteinGPS™ and GeneGPS™, is drastically speeding up the process of engineering […]

PALO ALTO, Calif. and WAYNE, Pa.-— Syapse, creators of the Precision Medicine Data Platform, today announced that it raised $10 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor, The Social+Capital Partnership. This financing will enable Syapse to extend its lead in helping healthcare providers deploy precision medicine […]

BOULDER, Colo. & BEVERLY, Mass.– Enzymatics today launches a new targeted sequencing assay for detecting and identifying fusions of 26 genes associated with sarcoma. Using Enzymatics’ proprietary Anchored Multiplex PCR™-based enrichment, fusions of all genes in the panel can be identified in a single sequencing run, without prior knowledge of fusion partners or breakpoints. The […]

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the opening of its new Italy head office and Customer Knowledge Center, which is located in the rapidly expanding scientific and academic district of Milano Bicocca University. The anticipated opening date is July 14, 2014. The Center […]

Provo, Utah — Tute Genomics, the leader in genome annotation and interpretation, today announced an agreement with Lineagen,Inc., to provide next-generation sequencing (NGS) analytics for Lineagen’s NextStepDx PLUS. Lineagen, focused on the diagnostic evaluation of neurodevelopmental and neurological disorders, currently offers FirstStepDx PLUS, a customized chromosomal microarray (CMA) testing service used by healthcare providers as […]

Cologne — AYOXXA Biosystems GmbH, an international biotechnology company, completed a € 9,0m Series B financing round by the end of June 2014. All of the company’s existing investors (High-Tech Gründerfonds, KfW, NRW.BANK, Wellington Partners Venture Capital and private investors) took part, along with new investors b-to-v Partners AG, Creathor Venture and HR Ventures. In […]

BOULDER, CO — InDevR, a Boulder-based life science company, announced today that it is now offering Titer on Chip as a service for rapid quantification of influenza hemagglutinin protein, the crucial ingredient in flu vaccines. Influenza Titer on Chip (Flu-ToC™) utilizes a panel of subtype-specific and broadly-reactive antibodies that enable reliable quantification of hemagglutinin (HA) […]

MADISON, WIS.-— Cellular Dynamics International, Inc. (CDI; Nasdaq: ICEL), today announced that the U.S. Patent and Trademark Office (PTO) awarded the company three patents on the reprogramming of human cells into pluripotent stem cells from human blood. Joining an IP portfolio of over 800 patents awarded to or in-licensed by CDI, these patents position the […]

METTLER TOLDEO is pleased to announce the launch of new EasyMax 102 and 402 Basic and Advanced personal synthesis workstations. These additions to the EasyMax family allow scientists to quickly identify and optimize new synthetic routes and eliminate non-viable reaction candidates. At a volume of 10-100 mL, EasyMax 102 is ideal for reaction screening and […]

MORGANTOWN, W.V. and SCHLIEREN, Switzerland — Protea Biosciences Group, Inc. (OTCQB:PRGB) and InSphero AG jointly announced today that they have entered into a collaboration that will combine each company’s respective 3D technology. InSphero AG is the leading supplier of 3D organotypic microtissues for in vitro toxicology and efficacy studies, with models derived from liver, pancreas, […]